Generer rapport
Human Bytes Aps
Svanemøllevej 65, 1, 2900 Hellerup, CVR 41719648
Virksomhedsform
Anpartsselskab
Etableret
2020
Størrelse
Mikro
Ansatte
2
Omsætning
-
DKK
Bruttofortj.
-1.450.788
DKK
Primært resultat (EBIT)
-4.903.218
DKK
Årets resultat
-4.957.463
DKK
Egenkapital
4.005.704
DKK
Reklamebeskyttet virksomhed
Denne virksomhed er reklamebeskyttet. Det betyder bl.a. at oplysningerne ikke må bruges til reklamehenvendelser. annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
534/550
"Bund 10%"
Rang i Danmark
335.870/343.349
"Bund 10%"
Direktion top 3
| Ulrik Juul Rokkedal Therkildsen 3 | CEO |
| Frederik Baastrup 2 | Direktør |
Bestyrelse top 3
| Lars Dahl Allerup 7 | Bestyrelsesformand |
| Frederik Baastrup 2 | Bestyrelsesmedlem |
| Ulrik Juul Rokkedal Therkildsen 3 | Bestyrelsesmedlem |
Legale ejere top 3
| 25-33.32% | Proxy Holding Aps | DK |
| 25-33.32% | Rokkedal Invest Aps | DK |
| 25-33.32% | T&W Medical A/S | DK |
Tegningsregler
Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening eller af den samlede bestyrelse.
Stamoplysninger baseret på CVR
| Navn | Human Bytes Aps |
| CVR | 41719648 |
| Adresse | Svanemøllevej 65, 1, 2900 Hellerup |
| Branche | Engroshandel med computere, ydre enheder og software [465100] |
| Web | www.humanbytes.ai |
| Etableret | 29-09-2020 (3 år) |
| Første regnskabsperiode | 29-09-2020 til 31-12-2021 |
| Virksomhedsform | Anpartsselskab |
| Antal ansatte | 3 (årsværk:2) |
| Reklamebeskyttelse | Ja |
| Revision fravalgt | Ja |
| Regnskabsperiode | 01-01 til 31-12 |
| Selskabskapital | 53.333 DKK 40.000 DKK (29-09-2020 - 29-03-2022) |
| Vedtægter seneste | 30-03-2022 |
Medlem af brancherne
- Engroshandel med computere, ydre enheder og softwareNACE6 indeholdende 755 virk.
- Engroshandel med informations- og kommunikationsudstyrNACE3 indeholdende 1.274 virk.
- Engroshandel undtagen med motorkøretøjer og motorcyklerNACE2 indeholdende 24.355 virk.
- Engroshandel og detailhandel, reparation af motorkøretøjer og motorcyklerNACE1 indeholdende 75.243 virk.
Formål
Virksomhedens formål er at sælge og markedsføre software, workflow løsninger og kunstig intelligens til sundhedssektoren samt dermed beslægtet virksomhed.
Regnskab
| 2022 | 2021 | |
|---|---|---|
| Valuta/enhed | 000' DKK | 000' DKK |
| Omsætning | - - | - - |
| Bruttofortjeneste | -1.451 - | 24 - |
| Årets resultat | -4.957 - | -15 - |
| Egenkapital | 4.006 - | 25 - |
| Balance | 6.194 - | 2.263 - |
Ledelsesberetning
Development in activities and financial and economic position
The company has during its second full year of operation focused on expanding the portfolio of world leading AI solutions for healthcare and engage in market dialogues across the Nordic market, to mature the customer readiness for AI and to start building commercial success. Since the company’s first successful installation late 2021 (AI for breast cancer screening in The Capital Region of Denmark), the company has been gaining traction in other parts of Denmark, and in the rest of the Nordics. In 2022, the company raised external capital from T&W Medical A/S with DKK 9M to support and accelerate the growth strategy. Since then, the company has expanded the portfolio with more products, and for some products also the territory (BeNeLux). In the second half of 2022, the company added three FTEs to the sales force in order to accelerate the execution of the growth strategy. Despite increasing traction and a growing need for AI in healthcare, the sales process is significantly longer than expected which leads to a delay in expected sales. Combined with higher staff costs, the overall financial result of 2022 represents a financial loss which leads to a result below expectations.
The company has during its second full year of operation focused on expanding the portfolio of world leading AI solutions for healthcare and engage in market dialogues across the Nordic market, to mature the customer readiness for AI and to start building commercial success. Since the company’s first successful installation late 2021 (AI for breast cancer screening in The Capital Region of Denmark), the company has been gaining traction in other parts of Denmark, and in the rest of the Nordics. In 2022, the company raised external capital from T&W Medical A/S with DKK 9M to support and accelerate the growth strategy. Since then, the company has expanded the portfolio with more products, and for some products also the territory (BeNeLux). In the second half of 2022, the company added three FTEs to the sales force in order to accelerate the execution of the growth strategy. Despite increasing traction and a growing need for AI in healthcare, the sales process is significantly longer than expected which leads to a delay in expected sales. Combined with higher staff costs, the overall financial result of 2022 represents a financial loss which leads to a result below expectations.
30-05-2023